TE
JANX icon

Tema ETFs’s Janux Therapeutics JANX Stock Holding History

Tema ETFs’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Buy
51,522
+333
+0.7% +$4.82K 0.03% 335
2026
Q1 		$712K Buy
51,189
+14,097
+38% +$193K 0.05% 297
2025
Q4 		$512K Sell
37,092
-3,259
-8% -$76.6K 0.04% 352
2025
Q3 		$986K Sell
40,351
-9,714
-19% -$237K 0.08% 261
2025
Q2 		$1.16M Buy
50,065
+4,128
+9% +$109K 0.31% 96
2025
Q1 		$1.24M Buy
45,937
+40,714
+780% +$1.53M 0.37% 80
2024
Q4 		$280K Buy
+5,223
New +$276K 0.12% 132

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Tema ETFs's JANX Position: Q2 2026 in Review

Tema ETFs increased its Janux Therapeutics (JANX) stake by 0.65% in Q2 2026, buying an estimated $4.82K and bringing the position to 51,522 shares worth $791K. The position accounts for 0.03% of the portfolio, ranked #335.

Tema ETFs first reported a position in JANX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.24M in Q1 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Tema ETFs held 51,522 shares of Janux Therapeutics worth $791K as of Q2 2026.
  • Tema ETFs bought 333 Janux Therapeutics shares in Q2 2026, an estimated $4.82K.
  • Janux Therapeutics made up 0.03% of Tema ETFs's portfolio in Q2 2026, its #335 holding.
  • Tema ETFs first reported a position in Janux Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Janux Therapeutics position peaked at $1.24M in Q1 2025.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.